Fifteen healthy controls (HC) and thirteen HIV-1+ subjects on ART provided ten pinch biopsies each from 3 sites: left colon (LC), right colon (RC) and terminal ileum (TI), via endoscopy and colonoscopy. Single cell suspensions were prepared by collagenase digestion, and CD45+ve/EpCam-ve lymphocytes analyzed by flow cytometry, including cell counts of IgA+CD19+CD27+ B cells and Tfh (CD3+CD4+CD45RO+CXCR5+PD-1high).
Median Tfh cell counts from HC subjects were 2743, 4526 and 9714 from LC, RC and TI biopsies respectively, which were not significantly different to corresponding median Tfh cell counts from HIV-1+ subjects (6840, 5236, and 3703, respectively). Median IgA+ B cell counts from HC subjects were 29704, 67780 and 30367 from LC, RC and Ti, respectively, and not significantly different to HIV-1+ subject cell counts (45333, 43641 and 35266, respectively). Cell counts for CD38high IgA+ plasmablasts were also not significantly different between the two subject groups.
In conclusion, HIV+ subjects on ART appeared to have intact GALT B cell responses in vivo, including Tfh and IgA+ B cell levels, comparable to healthy adult controls